Oaktree Acquisition Corp. III Life Sciences

Oaktree Acquisition Corp. III Life Sciences is a newly organized blank check company incorporated on June 28, 2024, as a Cayman Islands exempted company. The company's primary purpose is to complete a merger, share exchange, asset acquisition, share purchase, reorganization, or similar business combination with one or more businesses. To date, its activities have been limited to organizational efforts, tasks related to its initial public offering, and the search for an initial business combination target. The company has not yet selected a specific business combination target and has not generated any operating revenues. It does not expect to generate operating revenues until it completes its initial business combination. While the company may pursue an acquisition opportunity in any business, industry, sector, or geographical location, it intends to focus on industries that align with its management team's background. Specifically, it aims to identify and acquire a business within the healthcare or healthcare-related industries. The company intends to target North American, British, or European companies in the biopharmaceutical, medical devices, diagnostics, and specialized healthcare services sectors, where its management has extensive investment experience. The company's sponsor is an affiliate of Oaktree, a registered investment adviser with global investment experience. Through this affiliation, Oaktree Acquisition Corp. III Life Sciences intends to leverage the Oaktree platform's capabilities and experience across healthcare or healthcare-related industries.